Results 51 to 60 of about 19,154,713 (300)

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz   +12 more
wiley   +1 more source

Combivet and BSEV Joint Summer School [PDF]

open access: yes, 2022
About COMBIVET AND BSEV JOINT SUMMER SCHOOL 2022. The Combivet and BSEV Joint Summer School is organized by the COMBIVET ERA Chair of Comparative Medicine in the Institute of Veterinary Medicine and Animal Sciences of the Estonian University of Life ...
Estonian University of Life Sciences
core  

Gender Inequity during the Ph.D.: Females in the Life Sciences Benefit Less from Their Integration into the Scientific Community

open access: yesSocial Sciences, 2018
Female researchers remain underrepresented in higher academic ranks, even within female-dominated fields, such as the life sciences. The phenomenon is often attributed to women’s lower publication productivity.
Nurith Epstein, Daniel Lachmann
doaj   +1 more source

A guide to preprinting for early-career researchers

open access: yesBiology Open, 2022
The use of preprints, research manuscripts shared publicly before completing the traditional peer-review process, is becoming a more common practice among life science researchers.
Cassandra L. Ettinger   +5 more
doaj   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani   +7 more
wiley   +1 more source

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben   +4 more
wiley   +1 more source

14th International Conference on Biosystems Engineering 2024 : Book of Abstracts : May 8-10 2024 in Tartu, Estonia [PDF]

open access: yes
Book of Abstracts. 14th International Conference on Biosystems Engineering 2024, May 8–10, 2024 Tartu, Estonia.
Estonian University of Life Sciences
core   +1 more source

Stressors and stress symptoms of Life Science educators in schools in Tshwane North

open access: yesSouth African Journal of Science, 2013
Increased workloads and curriculum changes have become an integral part of the teaching profession. Knowledge of the major stressors and stress symptoms of teachers is required for proper stress management.
Magdalena J.A. Crafford   +1 more
doaj   +1 more source

Frontier of life science [PDF]

open access: yesJournal of Molecular Cell Biology, 2013
Cheng, Z., Ito, S., Nishio, N., et al. (2011). Establishment of induced pluripotent stem cells from aged mice using bone marrow-derived myeloid cells. J. Mol. Cell Biol. 3, 91–98.
openaire   +2 more sources

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy